Wedbush Investment Firm Reiterates Its Rating For This Biotech Company

Tyra Biosciences: A Closer Look at the Outperform Rating by Wedbush.

Disclosure: This post includes affiliate links. If you purchase anything through these affiliated links, the author/company may earn a commission.

On a recent note, Wedbush Securities, a renowned investment firm, reiterated its Outperform rating on Tyra Biosciences, maintaining a $27 price target. This decision has sparked conversations and debates among…